Ten Most Important Things to Know About Caring for Transgender Patients

被引:31
作者
Chipkin, Stuart R. [1 ,2 ]
Kim, Fred [3 ]
机构
[1] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA
[2] Valley Med Grp, Amherst, MA USA
[3] Valley Med Grp, Florence, MA USA
关键词
Cross-sex hormone therapy; Female to male; Male to female; Transgender; Transsexual; SEX HORMONE-TREATMENT; TRANSSEXUAL SUBJECTS; VENOUS THROMBOEMBOLISM; POSTMENOPAUSAL WOMEN; ANDROGEN DEFICIENCY; MORTALITY; THERAPY; HEALTH; CANCER; MEN;
D O I
10.1016/j.amjmed.2017.06.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transgender people have a gender that is not in agreement with their birth sex. Previous barriers, including lack of provider knowledge, have created significant healthcare disparities for this population. Recent societal changes are increasing the numbers of transgender people seen by primary care practitioners. Ten key principles are provided to help primary care practitioners create more welcoming environments and provide quality care to transgender patients. Overall, all members of the healthcare team (primary and specialty) need to become aware of the transition process and maintain communication regarding risks, benefits, and goals. Transwomen (aka male to female) can be treated with estrogens, antiandrogens, or a combination. Benefits include change in fat distribution, skin softening, and breast development. Significant risks for thrombosis from estrogens have been linked to genetic mutations, smoking, prolonged inactivity, and hormone formulation. Oral administration may provide increased risk over peripheral administration. Transmen (aka female to male) can be treated with peripheral testosterone preparations. Benefits include deepening of voice and development of facial and body hair with variable changes in muscle mass. Risks from testosterone appear to be less common than from estrogen. Laboratory monitoring can guide treatment decisions and provide early detection of some complications. Monitoring of "existing" anatomy (either hormonally or surgically created or removed) is an important component of healthcare for transgender patients. Primary care providers also should be aware of resources in their community and online, which can help patients optimize their transition. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:1238 / 1245
页数:8
相关论文
共 39 条
[11]   Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta-analyses [J].
Elamin, Mohamed B. ;
Garcia, Magaly Zumaeta ;
Murad, Mohammad Hassan ;
Erwin, Patricia J. ;
Montori, Victor M. .
CLINICAL ENDOCRINOLOGY, 2010, 72 (01) :1-10
[12]   Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects [J].
Elbers, JMH ;
Giltay, EJ ;
Teerlink, T ;
Scheffer, PG ;
Asscheman, H ;
Seidell, JC ;
Gooren, LJG .
CLINICAL ENDOCRINOLOGY, 2003, 58 (05) :562-571
[13]   Comparison of regimens containing oral micronized progesterone or medroxyprogesterone acetate on quality of life in postmenopausal women: A cross-sectional survey [J].
Fitzpatrick, LA ;
Pace, C ;
Wiita, B .
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2000, 9 (04) :381-387
[14]  
Flores AR., 2016, How Many Adults Identify as Transgender in the United States?
[15]  
Gates G.J., 2011, How many people are lesbian, gay, bisexual and transgender?
[16]   THE IMPACT OF LONG-TERM TESTOSTERONE REPLACEMENT THERAPY ON LIPID AND LIPOPROTEIN PROFILES IN WOMEN [J].
GOH, HH ;
LOKE, DFM ;
RATNAM, SS .
MATURITAS, 1995, 21 (01) :65-70
[17]   Long-term treatment of transsexuals with cross-sex hormones: Extensive personal experience [J].
Gooren, Louis J. ;
Giltay, Erik J. ;
Bunck, Mathijs C. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (01) :19-25
[18]   Breast Cancer Development in Transsexual Subjects Receiving Cross-Sex Hormone Treatment [J].
Gooren, Louis J. ;
van Trotsenburg, Michael A. A. ;
Giltay, Erik J. ;
van Diest, Paul J. .
JOURNAL OF SEXUAL MEDICINE, 2013, 10 (12) :3129-3134
[19]   Review of studies of androgen treatment of female-to-male transsexuals: Effects and risks of administration of androgens to females [J].
Gooren, Louis J. G. ;
Giltay, Erik J. .
JOURNAL OF SEXUAL MEDICINE, 2008, 5 (04) :765-776
[20]  
Grant J. M., 2010, NATL TRANSGENDER DIS